Moira McMahon
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
MOIRA MCMAHON, Johns Hopkins University, Baltimore
The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for patients infected with both viruses. Derek Thorne got the details from Moira McMahon from Johns Hopkins University in Baltimore. .
MOIRA MCMAHON, Johns Hopkins University, Baltimore
The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for patients infected with both viruses. Derek Thorne got the details from Moira McMahon from Johns Hopkins University in Baltimore. .
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.